SCP Investment’s Myovant Sciences Ltd. MYOV Stock Holding History

SCP Investment’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-20,000	Closed	-$253K	–	63
2017 Q4	$253K	Buy	+20,000	New	+$268K	0.26%	39

Other funds holding MYOV

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NCM

NovaQuest Capital Management Raleigh, North Carolina $54.3M AUM 163.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

SCP Investment's MYOV Position: Q1 2018 in Review

SCP Investment sold out of Myovant Sciences Ltd. (MYOV) in Q1 2018, closing a stake of 20,000 shares — an estimated $253K sold.

SCP Investment first reported a position in MYOV in Q4 2017 and held it in 1 quarter. The position peaked at $253K in Q4 2017. 32 funds tracked by Wall St. Rank hold MYOV as of Q1 2018.

SCP Investment reported no remaining Myovant Sciences Ltd. position as of Q1 2018 after selling out during the quarter.
SCP Investment sold 20,000 Myovant Sciences Ltd. shares in Q1 2018, an estimated $253K.
SCP Investment first reported a position in Myovant Sciences Ltd. in Q4 2017 and held it in 1 quarter.
SCP Investment's Myovant Sciences Ltd. position peaked at $253K in Q4 2017.
32 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2018.

Based on SCP Investment's 13F filing for Q1 2018, filed 15 May 2018.